Weighted Average Number of Shares Outstanding, Diluted of VitaNova Life Sciences Corp from 25 Jan 2017 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
VitaNova Life Sciences Corp quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 25 Jan 2017 to 31 Jan 2026.
  • VitaNova Life Sciences Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Jan 2026 was 8,337,454, unchanged year-over-year.
  • VitaNova Life Sciences Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 25,012,270, a 135% increase from 2023.
  • VitaNova Life Sciences Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 10,643,395, a 81% increase from 2022.
  • VitaNova Life Sciences Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 5,871,250, unchanged from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

VitaNova Life Sciences Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 8,337,454 +31 0% 01 Nov 2025 31 Jan 2026 10-Q 16 Mar 2026 2026 Q3
Q3 2025 25,012,270 0 0% 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 25,012,270 0 0% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2026 Q1
Q1 2025 25,012,270 +14,368,875 +135% 01 Feb 2025 30 Apr 2025 10-K 24 Jul 2025 2025 FY
Q4 2024 8,337,423 +2,258,118 +37% 01 Nov 2024 31 Jan 2025 10-Q 16 Mar 2026 2026 Q3
Q3 2024 25,012,270 +19,141,020 +326% 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q2
Q2 2024 25,012,270 +19,141,020 +326% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2026 Q1
Q1 2024 10,643,395 +4,772,145 +81% 01 Feb 2024 30 Apr 2024 10-K 24 Jul 2025 2025 FY
Q4 2023 6,079,305 +208,055 +3.5% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 5,871,250 0 0% 01 Aug 2023 31 Oct 2023 10-Q 13 Dec 2024 2025 Q2
Q2 2023 5,871,250 0 0% 01 May 2023 31 Jul 2023 10-Q 10 Sep 2024 2025 Q1
Q1 2023 5,871,250 0 0% 01 Feb 2023 30 Apr 2023 10-K 29 Jul 2024 2024 FY
Q4 2022 5,871,250 0 0% 01 Nov 2022 31 Jan 2023 10-Q 11 Mar 2024 2024 Q3
Q3 2022 5,871,250 0 0% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q2
Q2 2022 5,871,250 0 0% 01 May 2022 31 Jul 2022 10-Q 14 Sep 2023 2024 Q1
Q1 2022 5,871,250 01 Feb 2022 30 Apr 2022 10-K 15 May 2023 2023 FY
Q4 2021 5,871,250 01 Nov 2021 31 Jan 2022 10-Q 16 Feb 2023 2023 Q3
Q3 2021 5,871,250 01 Aug 2021 31 Oct 2021 10-Q 14 Nov 2022 2023 Q2
Q2 2021 5,871,250 01 May 2021 31 Jul 2021 10-Q 01 Sep 2022 2022 Q1
Q4 2018 5,871,250 0 0% 01 Nov 2018 31 Jan 2019 10-Q 15 Mar 2019 2019 Q3
Q3 2018 5,871,250 +1,734,742 +42% 01 Aug 2018 31 Oct 2018 10-Q 18 Dec 2018 2019 Q2
Q2 2018 5,871,250 +2,371,250 +68% 01 May 2018 31 Jul 2018 10-Q 17 Aug 2018 2019 Q1
Q1 2018 4,836,315 01 Feb 2018 30 Apr 2018 10-K 17 Jul 2018 2018 FY
Q4 2017 5,871,250 01 Nov 2017 31 Jan 2018 10-Q 15 Mar 2019 2019 Q3
Q3 2017 4,136,508 01 Aug 2017 31 Oct 2017 10-Q 18 Dec 2018 2019 Q2
Q2 2017 3,500,000 01 May 2017 31 Jul 2017 10-Q 17 Aug 2018 2019 Q1

VitaNova Life Sciences Corp Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 25,012,270 +14,368,875 +135% 01 May 2024 30 Apr 2025 10-K 24 Jul 2025 2025 FY
2023 10,643,395 +4,772,145 +81% 01 May 2023 30 Apr 2024 10-K 24 Jul 2025 2025 FY
2022 5,871,250 0 0% 01 May 2022 30 Apr 2023 10-K 29 Jul 2024 2024 FY
2021 5,871,250 0 0% 01 May 2021 30 Apr 2022 10-K 15 May 2023 2023 FY
2020 5,871,250 01 May 2020 30 Apr 2021 10-K 16 May 2022 2022 FY
2017 4,836,315 +1,336,315 +38% 01 May 2017 30 Apr 2018 10-K 17 Jul 2018 2018 FY
2016 3,500,000 26 Jan 2016 25 Jan 2017 10-K 17 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.